KR101894173B1 - Viral inactivating apparatus - Google Patents

Abstract

According to one embodiment, the virus inactivating device comprises a virus inactivating kit for accommodating a sample containing the virus; And a light emitting module including a plurality of light emitting devices for irradiating light to the virus deactivation kit.

Description

[0001] VIRAL INACTIVATING APPARATUS [0002]

The following description relates to a virus inactivating device.

Viruses are very threatening to human and animal life. Therefore, it is very important to analyze the early detection and characteristics of viral pathogens. In addition, detection of viruses is important not only in determining treatment strategies, but also in identifying the prevalence of other viruses, such as serotypes or isolates.

For the diagnosis of viral diseases, several testing methods can be carried out, starting with traditional microscopy and up to the recent MALDI-TOF mass spectrometry. In particular, MALDI-TOF mass spectrometry is a method of measuring the molecular weight of a sample, which is more reliable than conventional methods and can analyze the characteristics of various viruses, and the conventional methods require a long time to cultivate the virus On the other hand, the advantages of sample preparation are simple and rapid.

Most of these methods take samples of viruses and carry them to laboratories. This process has the potential to expose pathogens to the outside, so invactivation of viruses is essential.

As a general, inactivating method, pasteurization, dry heat, acidic substances and surfactants have been used. These methods are not suitable for MALDI-TOF mass spectrometry, which measures the molecular weight of proteins and DNA fragments, because they can inactivate the virus to prevent replication, but can destroy the virus's proteins.

Therefore, for the MALDI-TOF mass spectrometry, it may be desirable to deactivate the nucleic acid by deactivating the nucleic acid, without destroying the protein of the virus, by UV radiation and addition of chemicals.

Therefore, in the process of extracting a virus sample and transporting it to a laboratory, a device for deactivating and simultaneously delivering a virus sample using ultraviolet radiation and chemical treatment is required.

It is an object of one embodiment to provide a virus inactivating device.

According to one embodiment, the virus inactivating device comprises a virus inactivating kit for accommodating a sample containing the virus; And a light emitting module including a plurality of light emitting devices for irradiating light to the virus deactivation kit.

The plurality of light emitting devices may include at least two types of light sources including a UV-A light source that emits UV-A light, a UV-C light source that emits UV-C light, and a visible light source that emits visible light.

The distance between the light emitting elements emitting the same kind of light among the plurality of light emitting elements may be larger than the interval between the light emitting elements emitting different kinds of light beams.

The light emitting module may further include a luminescent panel having a length longer than a width of the luminescent panel. The luminescent panel may include a first light source that emits light of any one of the plurality of light emitting devices, The two light sources may be arranged alternately along the longitudinal direction of the luminescent panel.

The plurality of light emitting devices may be formed in a lattice pattern arranged at regular intervals.

The plurality of light emitting devices may be arranged at regular intervals from each other, and the rows or columns of the arrangement may be zigzag.

The light emitting module may further include a light emitting panel formed in a cylindrical shape, and the plurality of light emitting devices may be arranged at regular intervals on the inner circumferential surface of the light emitting panel.

According to an embodiment, the virus inactivation apparatus may include a light emission control unit for simultaneously or selectively operating the two or more kinds of light sources; And an interface unit installed to be exposed to the outside of the chamber and receiving a command of a user to be transmitted to the light emission control unit.

  The light emission control unit may selectively control the type of light emitted by the light emitting module according to the kind of chemical added to the sample.

According to an embodiment, the virus inactivating device may include at least one light source of at least one of a UV-C light source and a visible light source, and the virus inactivation kit may include at least one of methylene blue, thiazole orange, At least one chemical selected from thioperielium and dipyridol.

According to an embodiment, the virus inactivating device may include at least one light source of at least one of a UV-A light source and a UV-C light source, and the virus inactivation kit may include at least one kind of light source selected from the group consisting of 4-aminomethylenetri Oxalate, and riboflavin.

According to one embodiment, the viral inactivating device comprises a tube containing a virus sample and can be deactivated at the same time as it is carried.

According to one embodiment, the virus inactivating apparatus can irradiate a tube having two or more kinds of light sources containing a virus sample for inactivating the virus sample.

According to one embodiment, even when a tube containing a virus sample is irradiated with two or more kinds of light sources, the virus inactivating device can uniformly irradiate the entire sample.

According to one embodiment, the virus inactivating device is adapted to detect the type of light source (UV-A, UV-C, visibly) that causes the chemical sample to act on the virus sample, Ray) can be selected.

1 is a diagram illustrating a virus inactivating apparatus according to an embodiment of the present invention.
2A is a diagram illustrating a virus inactivation kit according to an embodiment.
2B is a cross-sectional view of a virus inactivation kit according to one embodiment.
3A is a diagram illustrating a virus inactivation kit according to an embodiment.
3B is a cross-sectional view of a virus inactivation kit according to one embodiment.
4 is a front view of a light emitting module according to an embodiment.
5 is a front view of a light emitting module according to an embodiment.
6 is a perspective view of a light emitting module according to an embodiment.
7 is a cross-sectional view of a virus inactivation kit according to one embodiment.
8 is a cross-sectional view of a virus inactivation kit according to one embodiment.
9 is a diagram illustrating a virus inactivating apparatus according to an embodiment.
10 is a diagram illustrating a virus inactivating apparatus according to an embodiment.

Hereinafter, embodiments will be described in detail with reference to exemplary drawings. It should be noted that, in adding reference numerals to the constituent elements of the drawings, the same constituent elements are denoted by the same reference symbols as possible even if they are shown in different drawings. In the following description of the embodiments, detailed description of known functions and configurations incorporated herein will be omitted when it may make the best of an understanding clear.

In describing the components of the embodiment, terms such as first, second, A, B, (a), and (b) may be used. These terms are intended to distinguish the constituent elements from other constituent elements, and the terms do not limit the nature, order or order of the constituent elements. When a component is described as being "connected", "coupled", or "connected" to another component, the component may be directly connected or connected to the other component, Quot; may be "connected," "coupled," or "connected. &Quot;

The components included in any one embodiment and the components including common functions will be described using the same names in other embodiments. Unless otherwise stated, the description of any one embodiment may be applied to other embodiments, and a detailed description thereof will be omitted in the overlapping scope.

1 is a view showing a virus inactivating apparatus 1 according to an embodiment.

Referring to FIG. 1, the virus inactivating apparatus 1 according to an embodiment may be a device for collecting a virus-containing sample, selectively adding chemicals, storing, transporting and deactivating the virus. For example, the virus inactivation apparatus 1 includes a case 11, a virus inactivating kit 12, a case terminal 13, a case battery 14, a power supply line 15, a case control unit (not shown) (16, 17).

The case 11 can supply power to the virus deactivation kit 12 or charge the chamber battery 124 of the virus deactivation kit 12, for example. For example, the case 11 may be portable, and may be fixedly mounted on a transportation means such as a vehicle where the virus inactivating apparatus 1 is installed.

As shown in Fig. 1, the case 11 of the embodiment can be formed as a rectangular parallelepiped, but the outer shape of the case 11 can have various shapes.

For example, the case 11 may include a receiving port 111 for placing the virus deactivation kit 12 in the case 11.

The receiving port 111 can be recessed from the upper surface of the case 11 as a space for accommodating the virus deactivation kit 12. [ The receiving port 111 may be formed in a shape corresponding to the outer shape of the virus deactivation kit 12. For example, the receiving port 111 may be a cylindrical inner space, as shown in Fig.

Also, a plurality of receiving ports 111 may be provided, and six receiving ports 111 may be formed as shown in FIG. 1, but only one receiving port 111 may be provided.

The virus deactivation kit 12 is a kit for inactivating a sample containing a virus sample, and may be a device for deactivating the virus of the sample and storing and transporting the sample. For example, the sample may contain additional chemicals for virus inactivation.

For example, the virus deactivation kit 12 includes a tube 121, a chamber 122, a light emitting module 123, a chamber battery 124, a chamber terminal 125, and an interface 126 (see FIG. And the detailed configuration will be described later with reference to Fig.

The case terminal 13 is a terminal for supplying power to the virus deactivation kit 12 and charging the chamber battery 124 of the virus deactivation kit 12, And may be disposed on the bottom surface of the receiving port 111 as shown in FIG.

For example, the case terminal 13 may contact the chamber terminal 125 of the virus deactivation kit 12 to provide power. On the other hand, the case 11 may include charging means capable of charging the chamber battery 124 wirelessly, without contacting the chamber terminal 125 directly.

The case battery 14 is a battery disposed in the case 11 and can be installed inside or outside the case 11 and can supply power supplied to the virus inactivating kit 12. [ According to the case battery 14, it is possible to supply power to the virus inactivation kit 12 while carrying the case 11 to the outside.

The power supply line 15 can supply electric power for operating the virus inactivating device 1 from the external power source to the case 11 through which the case battery 14 can be charged.

The case control unit (not shown) can control the electric power transmitted from the case terminal 13 to the virus deactivation kit 12 and can sense the amount of charge of the case battery 14 and the chamber battery 124. [

The display units 16 and 17 are devices for displaying the charged amounts of the case batteries 14 and the chamber batteries 124 sensed by the case control unit and may be installed on the outer surface of the case 11. [

1, the display units 16 and 17 include a case battery indicator 16 for indicating the amount of charge of the case battery 14 and a battery indicator 16 for indicating the amount of charge of the virus inactivating kit 12 contained in the receiving port 111 And a chamber battery indicator 17 for indicating a charged amount of the chamber battery 124. [

1, the case battery indicator 16 may be disposed on the upper right side of the upper surface of the case 11, and the chamber battery indicator 17 may be provided for each receiving port 111, for example, And can be disposed near the entrance of the receiving port 111 on the upper surface of the case 11.

2A and 2B illustrate a virus inactivation kit 12 according to one embodiment. Specifically, FIG. 2A shows a perspective view of a virus inactivation kit according to an embodiment, and FIG. Lt; / RTI > of the virus inactivating kit according to the present invention.

Referring to FIGS. 2A and 2B, the virus deactivation kit 12 according to one embodiment is a device that can inactivate a sample containing a virus sample and grasp and transport the sample. For example, the virus deactivation kit 12 may be accommodated in the receiving port 111 of the case 11 and operated by receiving power. For example, the virus deactivation kit 12 may include a case 11 ) And may operate independently.

The virus deactivation kit 12 includes a tube 121, a chamber 122, a light emitting module 123, a chamber battery 124, a chamber terminal 125, a light emission control unit (not shown) and an interface unit 126 can do.

The tube 121 is a container for storing a sample containing a virus and can be attached to the inner space 1221 of the chamber 122, which will be described later. Here, the sample may be a living tissue or blood collected from an animal infected with a virus, and a chemical may optionally be added to the sample. Chemical substances will be described with reference to Table 1 to be described later.

For example, the tube 121 may be disposable, and after the sample is stored, a cover may be attached from the top so that the airtightness can be maintained. The cover may have a material and / or a color that can block light other than light emitted from a light emitting module 123, which will be described later.

The tube 121 may be made of a material having good light transmittance as a material of the tube 121 in order to pass light through the light emitting module 123 to be described later and deactivate the virus of the sample. For example, And may be formed of one or more materials selected from the group consisting of polytetrafluoroethylene, glass, and quartz.

The chamber 122 can receive the tube 121 and can inactivate the virus in the sample inside the tube 121. For example, the chamber 122 may have a length longer than the width as shown in Figs. 2A and 2B, and may have a columnar shape with a circular cross-section. However, it is needless to say that the horizontal and vertical ratios of the chamber 122 can be freely formed, and that the cross section is formed in various shapes such as a triangle, a square, and the like.

For example, the chamber 122 may include an interior space 1221 for receiving a sample, and the chamber 122 may also include an inlet 127 (not shown) for receiving the tube 121 at the top, A body portion 128 from the inlet portion 127 to the inner space 1221 and a distal portion 129 from the body portion 128 to the lower end of the chamber 122.

The inner space 1221 may be a space that is depressed from the center of the upper surface of the chamber 122 and may extend from the inlet portion 127 to the lower end of the body portion 128. As shown in Figures 2A and 2B, The diameter or width of the tube 1221 may be larger than that of the tube 121.

The width of the outer periphery of the inlet portion 127 of the chamber 122 may be larger than the width of the outer periphery of the body portion 128 and the distal end portion 129. [ For example, as shown in FIG. 2A, the diameter of the outer periphery of the inlet portion 127 is larger than the diameter of the body portion 128 and the distal end portion 129 so that the body portion 128 and the inlet portion 127 are connected The outer surface in the section may be formed to be inclined.

The user can easily grasp the chamber 122 without missing the chamber 122 and the receiving port 111 of the case 11 can be easily gripped by the chamber 122 having the wider outer edge of the inlet 127. [ The virus inactivation kit 12 can be easily separated from the case 11 by gripping the protruding portion of the inlet portion 127. [

The light emitting module 123 is an apparatus for emitting light toward the tube 121 and may include a plurality of light emitting elements arranged on a panel and a panel.

In addition, the light emitting module 123 may include at least one of a UV-A light source, a UV-C light source, and a visible light source. The detailed configuration of the light emitting module 123 will be described later with reference to Figs.

2A and 2B, a plurality of light emitting devices may be arranged in a line on the outer surface of the panel, and the center of the inner space 1221 may be formed on the outer circumferential surface of the inner space 1221. For example, At least one light emitting module 123 may be installed.

As shown in FIGS. 2A and 2B, a plurality of light emitting modules 123 may be installed at regular intervals along the circumference of the inner space 1221. It is to be understood that the position, shape and number of the light emitting module 123 provided in the virus deactivation kit 12 can be arbitrarily selected by a person skilled in the art while performing the installation, Various embodiments will be described later with reference to Figs.

The chamber battery 124 can supply power for operating the light emitting module 123. [ For example, the chamber battery 124 may be received in a battery receiving groove 1291 formed in the distal end 129, as shown in FIG. 2B.

The chamber battery 124 is also exchangeable and can be detached from the terminal portion 129 for the replacement of the chamber battery 124. The battery accommodating groove 1291 can be detached from the terminal portion 129, Cover 1292 as shown in FIG.

The chamber terminal 125 may be disposed on the outer wall of the chamber 122 as a terminal for receiving electric power from the case terminal 13 of the case 11 and may be disposed on the outer wall of the chamber 122, As shown in FIG.

In this case, the case terminal 13 can be disposed on the lower surface of the receiving port 111, and the virus inactivation kit 12 is placed in the receiving port 111, (13). In this way, the virus deactivation kit 12 can receive electric power, operate the light emitting module 123, and charge the chamber battery 124.

For example, in the case where the light emitting module 123 includes at least two kinds of light sources, the light emitting control unit (not shown) may control the operation of the light emitting module 123, .

The interface unit 126 is an apparatus for receiving a command from a user and transmitting the command to a light emission control unit (not shown). The interface unit 126 may be exposed to the outside of the chamber 122 so as to be operated by a user, The interface section 126 may be provided on the outer surface of the inlet section 127 as shown in Fig.

According to this structure, the user can operate the interface unit 126 provided outside the chamber 122 to output an input signal for controlling the power supply of the light emitting module 123 and the desired light source type. The interface unit 126 may include a plurality of buttons corresponding to the type of light source or a plurality of buttons corresponding to chemicals to be added to the sample.

The input signal may be transmitted to a light emission control unit (not shown), and a light emission control unit (not shown) may operate the light emission module 123 according to the input signal. In particular, It is possible to selectively control the type of light.

On the other hand, a chemical substance may be selectively added to the tube 121 in order to deactivate the virus. In this case, depending on the chemicals to be added, in order to effectively deactivate the virus, the type of light source emitted by the light emitting module 123 needs to be selectively controlled.

Table 1 below shows the chemical substances that can be added to the sample and the light sources corresponding to the chemical substances.

No. Chemical UVA UVC Visible
light No
Light One Methylene blue Y Y 2 4'-Aminomethyltrioxsalen Y Y 3 Riboflavin Y Y 4 Thiazole Orange Y Y 5 Thiopyrylium Y Y 6 Dipyridamole Y Y

Referring to Table 1, the samples include Methylene blue, 4'-Aminomethyltrioxsalen, Riboflavin, Thiazole Orange, Thiopyrylium and Dipyridamole, and the kind of the light emitting device to be controlled can be identified according to the chemical substance. For example, according to Table 1, it can be confirmed that when methylene blue is added, it is preferable to use a UV-C light source and / or a visible light source in order to deactivate the virus of the sample.

The UV-A light source and / or visible light source may activate the corresponding chemical in Table 1, and the activated chemical may react with the virus to inactivate the virus. After the chemical is activated to deactivate the virus, the UV-A light source and / or the visible light source may no longer irradiate UV-A and / or visible light. Once the virus is inactivated, the UV-C light source can be irradiated with UV-C light to maintain the virus inactivated state.

In one example, the plurality of light emitting elements include at least one light source of a UV-C light source and a visible light source, and the virus inactivating kit may include at least one chemical substance of methylene blue, thiazole orange, thioperielium, . ≪ / RTI > As another example, the plurality of light-emitting elements include at least one light source of a UV-A light source and a UV-C light source, and the virus inactivation kit contains at least one chemical substance of 4-aminomethylenetrioxalene and riboflavin can do.

3A and 3B illustrate a virus inactivation kit 22 according to one embodiment. Specifically, FIG. 3A shows a perspective view of a virus inactivation kit according to an embodiment, and FIG. Lt; / RTI > of the virus inactivating kit according to the present invention.

3A and 3B, the virus deactivation kit 22 according to one embodiment includes a tube 222, a chamber 222 including an inner space 2221, a light emitting module 223, a chamber battery 224, An interface unit 225, and an interface unit 226.

The light emitting module 223 may be attached to the outer surface of the chamber 222 rather than the inner space 2221. [ For example, the light emitting module 223 may be installed along the perimeter of the body of the chamber 222 as shown in FIGS. 3A and 3B, and may be provided at a plurality of intervals.

The light emitting module 223 may be installed not only on the outer surface of the chamber 222 but also between the outer surface of the chamber 222 and the inner space 2221.

In this way, when the light emitting module 223 is installed outside the internal space 2221 of the chamber 222, the light emitted from the light emitting module 223 is irradiated toward the sample in the internal space 2221 And the chamber 222 may be made of a material having good light transmittance, and may be formed of at least one of polytetrafluoroethylene, glass, and quartz.

4 is a front view of a light emitting module according to an embodiment.

Referring to FIG. 4, the light emitting module 323 according to one embodiment may include a panel 3231 and a plurality of light emitting devices 3232. Here, the panel 3231 may be a substrate having a thin thickness, in which a plurality of light emitting devices 3232 are provided.

For example, the light emitting module 323 may be installed in the virus deactivation kit 12 as shown in Figs. 1 to 3B, and may be installed inside the receiving port 111 of the case 11, It can also be installed.

The plurality of light emitting elements 3232 may be light emitting diodes which are provided on the outer surface of the panel 3231 and emit light. For example, the plurality of light emitting devices 3232 may include at least one type of light source such as a UV-A light source 3232a, a UV-C light source 3232b, and a visible light source 3232c.

The UV-A light source 3232a may be an element that emits ultraviolet light in a region between 315nm and 400nm and the UV-C light source 3232b may be an element that emits ultraviolet light in a region between 200nm and 280nm. And visible light source 3232c may be an element that emits visible light between 400 nm and 700 nm.

4, the UV-A light source 3232a, the UV-C light source 3232b, and the visible light source 3232b may include only one kind of light source, for example, May be included.

As shown in FIG. 4, the panel 3231 may be formed long in the longitudinal direction, and accordingly, the plurality of light emitting devices 3232 may be arranged in a line in the light emitting panel 3231. For example, when the light emitting module 323 includes two or more kinds of light sources, the plurality of light emitting elements may be arranged alternately in the longitudinal direction.

As described above, by arranging the plurality of light emitting devices 3232 alternately, when the light emitting module 323 emits light toward the tube 121, the specific light source is not shifted to only one part, It can be uniformly irradiated.

5 is a front view of a light emitting module according to an embodiment.

Referring to FIG. 5, the light emitting module 423 according to one embodiment may include a panel 4231 and a plurality of light emitting devices 4232. Here, the plurality of light emitting devices 4232 may be arranged on the panel 4231 by being arranged long in the longitudinal direction in two rows.

In the case where the plurality of light emitting devices 4232 are arranged in two or more rows, the spacing between the plurality of light emitting devices 4232 adjacent to each other may be constant. In addition, Lt; RTI ID = 0.0 > zigzag < / RTI >

5, when a plurality of light emitting devices includes the UV-A light source 4232a, the UV-C light source 4232b, and the visible light source 4232c, the interval between adjacent light sources of the same kind is May be arranged to be larger than the spacing between the light sources of the same kind.

Accordingly, when the light emitting module 423 including at least two types of light sources emits light toward the sample, the specific light source can be uniformly irradiated to the entire sample without being deviated to only one part.

6 is a perspective view of a light emitting module according to an embodiment.

Referring to FIG. 6, the light emitting module 523 according to one embodiment may include a light emitting panel 5231 and a plurality of light emitting devices 5232

The luminescent panel 5231 may be formed in a cylindrical shape having a thin substrate as shown in Fig. 6, and a plurality of light emitting elements 5232 may be arranged on the inner circumferential surface of the luminescent panel 5231 at regular intervals.

For example, the light emitting module 523 may be installed in the virus deactivation kit 12 or in the receiving port 111 of the case 11, as shown in Fig. An embodiment related to this will be described later with reference to Figs. 7, 8, and 10. Fig.

According to such a structure, the tube 121 containing the sample can be positioned at the center of the inside of the light emitting module 523, and in this case, it is possible to effectively irradiate light uniformly throughout the sample.

7 is a cross-sectional view of a virus inactivation kit according to one embodiment.

7, a virus inactivation kit 52 according to one embodiment includes a tube 522 including a tube, an internal space 5221, a light emitting module 523, a chamber battery 524, and a chamber terminal 525 ).

The light emitting module 523 may be installed on the inner peripheral surface of the inner space 5221 of the chamber 522, for example. The plurality of light emitting devices 5232 of the light emitting module 523 are arranged closely along the inner circumferential surface of the inner space 5221 and emit light toward the center of the inner space 5221, It is possible to effectively deactivate the sample of the tube to be inserted into the tube.

8 is a cross-sectional view of a virus inactivation kit according to one embodiment.

8, a virus inactivation kit 62 according to one embodiment includes a tube 622, a light emitting module 623, a chamber battery 624, and a chamber terminal 622 ).

The light emitting module 623 may be installed on the outer wall of the chamber 622, for example. Since the light emitting module 623 is installed along the outer wall of the chamber 522, a plurality of light emitting devices can be closely arranged around the outer wall of the chamber 522.

9 is a diagram illustrating a virus inactivating apparatus according to an embodiment.

Referring to FIG. 9, the virus inactivation apparatus 7 according to an embodiment includes a virus inactivating kit 721 and a virus inactivating apparatus 1 shown in FIG. 1, Unlike the case of receiving the virus inactivating kit 12 including the tube 121 and the virus inactivating kit 12 including the tube 121,

For example, the virus inactivating device 7 includes a case 71 including a receiving port 711, a tube 721, a light emitting module 723, a case battery 74, a power supply line 75, (Not shown) and a display unit 76. [

The receiving port 711 can receive the tube 721 and can be, for example, a space formed in a cylindrical shape. The tube 721 is a space in which a sample containing viruses is stored, and a tube 721 such as the tube 121 of FIG. 2A can be used.

The light emitting module 723 is installed in the receiving port 711 and can irradiate light toward the tube 721 inserted into the receiving port 711. [ 9, a plurality of light emitting modules 723 may be provided on the inner wall of the receiving port 711 in a row.

On the other hand, the light emitting module 723 may be provided outside the inner circumferential surface of the receiving port 711, that is, inside the case 71, in order to irradiate light into the receiving port 711. In this case, the material of the case 71 may be formed of a material having good light permeability, and specifically, it may be formed of any one or more of polytetrafluoroethylene, glass, and quartz.

The case battery 74 may be installed in the case 71 to provide electric power for operating the light emitting module 723. [

The power supply line 75 can provide power to operate the light emitting module 723 from the external power supply to the case 71 through which the case battery 74 can be charged.

The case control unit (not shown) can sense the charged amount of the case battery 74 and can control the operation of the light emitting module 723. [ For example, when the light emitting module 723 includes at least two kinds of light sources, the two or more kinds of light sources can be controlled simultaneously or selectively.

The display unit 76 may display the charged amount of the case battery 74 detected by the case control unit (not shown).

10 is a diagram illustrating a virus inactivating apparatus according to an embodiment.

Referring to FIG. 10, the virus inactivation apparatus 8 according to an embodiment includes a virus inactivation kit 82b and a virus inactivation kit 82b, as well as a tube 821a ) May be accommodated alone.

The virus inactivating device 8 includes a case 81, a tube 821a, a virus inactivating kit 82b, a case terminal 83, a light emitting module 823a, a case battery 84, a power supply line 85, (Not shown) and display portions 86 and 87.

The case 81 can accommodate the virus deactivation kit 82b to supply power to the virus deactivation kit 82b and charge the chamber battery 824b of the virus deactivation kit 82b.

The case 81 can directly accommodate the tube 821a in which the sample containing the virus is stored and has a plurality of receiving ports 811a for accommodating the virus deactivation kit 82b and the tube 821a , 811b.

The accommodating ports 811a and 811b may be a space formed by being recessed from the upper surface of the case 81 and accommodating the first accommodating port 811a and the virus inactivating kit 82b for accommodating the tube 821a And a second receiving port 811b.

The first receiving port 811a is a port for receiving the tube 821a and may be a cylindrical space as shown in Fig. 10, and a light emitting module 823a may be provided on the inner wall.

The second receiving port 811b is a port for receiving the virus deactivation kit 82b and may be formed in a cylindrical space as shown in Fig. 10, and the width of the second receiving port 811b may be a width 811a. For example, a case terminal 83 may be provided in the second receiving port 811b.

The tube 821a is a container in which a sample containing viruses is stored, can be a disposable container, can be replaced, and can be a tube 821a like the tube 121 in Fig. 2a. For example, chemicals for virus inactivation may be added to the sample.

The virus deactivation kit 82b is a kit for deactivating a sample containing a virus sample, storing and transporting the sample, and is housed in a second receiving port 811b of the case 81, , The chamber battery 824b, and may be configured, for example, as the virus deactivation kit 12 shown in FIG. 2A.

For example, the virus deactivation kit 82b may include a tube 821a, a chamber 822b, a light emitting module 823b, a chamber battery 824b, a chamber terminal 825b, and an interface.

The detailed structure of the virus deactivation kit 82b may also be the same as the virus deactivation kit 12 shown in Fig. 2A, but the configuration of the light emitting module 823b may be modified in various ways, Arrangement and type of light source can be freely modified.

The case terminal 83 can be disposed in the second receiving port 811b as a terminal for supplying power to the virus deactivation kit 82b and for charging the chamber battery 824b of the virus deactivation kit 82b May be disposed on the bottom surface of the second accommodating port 811b as shown in Fig. 1, and may be in contact with the chamber terminal 825b.

The light emitting module 823a is a device for irradiating light toward the sample and can be installed in the first receiving port 811a and the light emitting module 823a having a cylindrical panel is mounted on the first receiving port 811a. The light emitting module 823a may have the same configuration as that of the light emitting module 823b provided in the virus deactivation kit 82b, and may be interchangeable.

For example, the light emitting module 823a may be installed inside the first accommodating port 811a, but may be inserted outside the inner wall of the first accommodating port 811a, that is, inside the case 81, It is possible. In this case, the case 81 needs to be formed of a material having excellent light transmittance.

As in the various embodiments of the light emitting modules 823a and 823b described above, the positions, arrangement, and types of light sources of the light emitting modules 823a and 823b can be freely modified.

The case battery 84 is a battery disposed in the case 81 and can supply electric power supplied to the virus inactivation kit 82b through the case terminal 83 and is provided in the first receiving port 811a The power supply for operating the light emitting module 823a may be provided. With the case battery 84, it is possible to operate the virus inactivating device 8 while carrying the case 81 to the outside.

The power supply line 85 can supply power from the external power source to the case 81 so that the virus inactivating device 8 can be operated and the case battery 84 can be charged. In addition, a power source for operating the light emitting module 823a provided in the first receiving port 811a can be provided.

The control unit (not shown) can control the power transmitted from the case terminal 83 provided in the second accommodation port 811b to the virus inactivation apparatus 1 and installed in the first accommodation port 811a The operation of the light emitting module 823 can be controlled. For example, when the light emitting module 823a includes at least two kinds of light sources, the two or more kinds of light sources can be controlled simultaneously or selectively.

In addition, the control unit (not shown) can sense the amount of charge of the chamber battery 824b of the case battery 84 and the virus deactivation kit 82b.

The display units 86 and 87 are devices for displaying the charged amount of the case battery 84 and the chamber battery 824b detected by the case control unit and may be installed on the outer surface of the case 81. [

1, the display units 86 and 87 include a case battery indicator 86 for indicating a charged amount of the case battery 84 and a virus inactivating kit (not shown) mounted in the second receiving port 811b And a chamber battery indicator 87 for indicating the amount of the chamber battery 824b charged in the chamber 82b.

10, the case battery indicator 86 may be disposed on the front surface of the case 81, and the chamber battery indicator 87 may be provided for each second receiving port 811b, And may be disposed near the entrance of the second receiving port 811b on the upper surface, but the position is not limited thereto.

Although the preferred embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that various modifications, additions and substitutions are possible, without departing from the scope and spirit of the invention as disclosed in the accompanying claims. For example, it is contemplated that the techniques described may be performed in a different order than the described methods, and / or that components of the described structures, devices, and the like may be combined or combined in other ways than the described methods, Appropriate results can be achieved even if they are replaced or replaced.

Therefore, other implementations, other embodiments and equivalents to the claims are within the scope of the following claims.

Claims (11)

A virus inactivating device for inactivating a virus contained in a sample,
A virus inactivating kit for accommodating a sample containing the virus; And
And a light emitting module including a plurality of light emitting devices for irradiating light to the virus deactivation kit,
Wherein the plurality of light emitting devices include at least two light sources of a UV-A light source emitting a UV-A light, a UV-C light source emitting a UV-C light, and a visible light source emitting visible light,
The virus inactivating device comprises:
A light emission control unit for simultaneously or selectively operating the two or more kinds of light sources; And
Further comprising an interface unit installed to be exposed to the outside of the virus inactivation kit and receiving an instruction of a user to be transmitted to the light emission control unit,
The light-
Wherein the type of the light emitted by the light emitting module can be selectively controlled according to the type of chemical substance added to the sample.
delete The method according to claim 1,
Wherein an interval between light emitting elements emitting the same kind of light among the plurality of light emitting elements is larger than an interval between light emitting elements emitting different kinds of light beams.
The method according to claim 1,
The light emitting module may further include a luminescent panel having a length longer than a width,
Wherein a first light source that emits a light beam of any one of the plurality of light emitting devices and a second light source that emits another light beam of the other kind are arranged alternately along the longitudinal direction of the light emitting panel.
The method according to claim 1,
Wherein the plurality of light emitting devices are formed in a lattice pattern arranged at regular intervals from each other.
The method according to claim 1,
Wherein the plurality of light emitting elements are arranged at regular intervals from each other, and rows or columns of the array are arranged in zigzags.
The method according to claim 1,
The light emitting module may further include a light emitting panel formed in a cylindrical shape,
Wherein the plurality of light emitting devices are arranged at regular intervals on an inner circumferential surface of the luminescent panel.
delete delete The method according to claim 1,
Wherein the plurality of light emitting devices include at least one light source of a UV-C light source and a visible light source,
Wherein the virus inactivating kit comprises at least one chemical substance selected from the group consisting of methylene blue, thiazole orange, thioperielium, and dipyramol.
The method according to claim 1,
Wherein the plurality of light emitting devices include at least one light source of a UV-A light source and a UV-C light source,
Wherein the virus inactivation kit comprises at least one chemical selected from the group consisting of 4-aminomethyltrioxalene and riboflavin.

Images